Research network relies on shoe-leather recruiting

February 2009
Clinical Trials Administrator;Feb2009, Vol. 7 Issue 2, p20
The article reveals the effectiveness of the old-fashioned method of recruiting pregnant women for clinical research, according to the Obstetrics and Gynecology Research Network (OGRN). According to Tonya K. Edvalson, a research compliance manager of obstetrics and gynecology, to recruit subjects, they go out in the community and establish relationships with physicians. Also, research nurses or assistants visit a clinic to spend time with the clinic's staff to let them know which studies are enrolling and who might be a candidate for them.


Related Articles

  • Adding Ancillaries: Clinical trials. Weiss, Barbara // Medical Economics;1/6/2006, Vol. 83 Issue 1, p53 

    The article presents the factors to be considered when planning to conduct a clinical trial. Study drugs must be stored in a secure place like a lockable cabinet. Designating a room as the study coordinator's office is also important. A good and competent clinical research coordinator is a must...

  • Adapting Smoking Relapse–Prevention Materials for Pregnant and Postpartum Women: Formative Research. Quinn, Gwendolyna; Ellison, Bethany Bell; Meade, Cathy; Roach, C. Nannette; Lopez, Elena; Albrecht, Terrance; Brandon, Thomas H. // Maternal & Child Health Journal;May2006, Vol. 10 Issue 3, p235 

    Objective: To decrease smoking relapse among pregnant and postpartum women by adapting existing, validated relapse–prevention materials to meet the unique needs of pregnant and postpartum women. Methods: A series of semi-structured interviews and learner verification activities were...

  • Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors.  // Annals of Internal Medicine;9/21/2004, Vol. 141 Issue 6, p477 

    This article presents a suggestive note on standards and procedures of clinical trial registration, based on a statement from the International Committee of Medical Journal Editors (ICMJE). The case against selective reporting is particularly compelling for research that tests interventions that...

  • Moving the needle on clinical trial recruitment. Oestreicher, Paul // Medical Marketing & Media;Nov2009, Vol. 44 Issue 11, p33 

    In this article, the author reflects on the factors affecting biopharmaceutical development. He includes the chronic shortage of patient volunteers which reasons include onclologists not wanting to refer patients away from their practices and record-keeping. He also mentions plain lack of...

  • Uptake of novel medical therapies in the general population. Booth, C. M.; Rapoport, B. // Current Oncology;Jun2011, Vol. 18 Issue 3, p105 

    The author reflects on the effectiveness of randomized controlled trial (RCT) in establishing the efficacy of new medical therapies. He cites the approval of the clinicians regarding the validity of RCT to understand how the result may relate to the patient care and outcomes in medical...

  • Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial. Oba, Koji; Morita, Satoshi; Rahman, Mahbubur; Sakamoto, Junichi // Trials;2006, Vol. 7, p26 

    Background: In order to minimize the amount of incomplete follow-up data, reducing the noncompliance of participating physicians is one of the key issues for the data coordinating center in a multi-center trial. Identifying the physicians' non-compliance in advance is considered to be an...

  • Assessment of Rheumatoid Arthritis in Clinical Care. Sokka, Tuulikki // Turkish Journal of Rheumatology;Mar2010, Vol. 25 Issue 1, p1 

    Quantitative clinical monitoring of patients with musculoskeletal conditions should be included in the infrastructure of every clinical practice. Quantitative monitoring improves the physician's capacity to assess and document a patient's clinical status and changes over time, which leads to...

  • Trials and tribulation. Torgerson, David // New Scientist;3/26/2005, Vol. 185 Issue 2492, p30 

    The article reports that most clinical trials do not have the statistical power to detect the incidence of relatively rare adverse events. Unfortunately, most adverse events come to light many years after a product has been licensed, by which time thousands, if not millions, of patients have...

  • Using Stories to Disseminate Research: The Attributes of Representative Stories. Steiner, John F. // JGIM: Journal of General Internal Medicine;Nov2007, Vol. 22 Issue 11, p1603 

    The article discusses how representative stories can help disseminate research effectively. Five attributes of representative stories are being suggested including expression of important themes in research, explicit location in the distribution of stories, verifiability, acknowledgement of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics